ASX · AVE.AX
Avecho Biotechnology Limited
A$0.01+A$0.00 (+7.69%)
Avecho Biotechnology Limited’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
Loading market information…
OTC · AMHV · USD
Stock price
Quote as of Mar 29, 2023, 06:08 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
American Hemp Ventures, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.82% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
American Hemp Ventures, Inc. is a company engaged in the hemp industry, offering a comprehensive selection of hemp seeds, genetic materials, finished products, and related services. Their product portfolio features Circa 1920, a skincare solution developed for anti-aging benefits, hydration, and overall dermal health, in addition to their HempSure brand of CBD supplements. The company maintains its headquarters in Aurora, Colorado.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
A$0.01+A$0.00 (+7.69%)
Avecho Biotechnology Limited’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
$2.74-$0.01 (-0.27%)
Organicell Regenerative Medicine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
$0.17-$0.03 (-13.04%)
Ceapro Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.39% below the high.
$8.50+$0.50 (+6.25%)
Eiger BioPharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
CA$0.11+CA$0.01 (+10.0%)
Rapid Dose Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 42.11% below the high.
A$0.05A$0.00 (0.0%)
Noxopharm Limited’s quoted price sits in the lower half of its reported 52-week range, 55.45% below the high.
€0.17-€0.00 (-1.98%)
Poxel S.A.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
£0.06-£0.00 (-1.72%)
OptiBiotix Health Plc’s quoted price sits in the lower half of its reported 52-week range, 36.67% below the high.
